logo
Select company
Select metric
Ticker Information

Ticker

ANAB

Company Name

ANAPTYSBIO INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ANAPTYSBIO INC - Enterprise Value over EBIT Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ANAB - EV/EBIT Historical data
DateEarning Before Interest & Taxes (EBIT)Enterprise ValueEnterprise Value over EBIT
6/30/2025$ -132.52M$ 933.21M0
3/31/2025$ -140.58M$ 856.38M0
12/31/2024$ -145.23M$ 749.32M0
9/30/2024$ -165.65M$ 780.4M0
6/30/2024$ -170.11M$ 1.2B0
3/31/2024$ -163.3M$ 990.45M0
12/31/2023$ -163.62M$ 917.57M0
9/30/2023$ -147.8M$ 733.73M0
6/30/2023$ -143.99M$ 783.55M0
3/31/2023$ -136.7M$ 781.89M0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ANAPTYSBIO INC's latest trailing twelve months (TTM) EV/EBIT stands at 0.
  • Over the past 5 years, ANAPTYSBIO INC's average EV/EBIT has been 75.5.
  • The median EV/EBIT for ANAPTYSBIO INC during this period was 75.5
  • ANAPTYSBIO INC reached its highest EV/EBIT over the past 5 years at 75.5.
  • The lowest EV/EBIT recorded by ANAPTYSBIO INC in the same timeframe 75.5

ANAPTYSBIO INC's EV/EBIT vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EV/EBIT Benchmarks
CompanyEV/EBIT
PHAT : PHATHOM PHARMACEUTICALS INC -NAGE : NIAGEN BIOSCIENCE INC 37.78GYRE : GYRE THERAPEUTICS INC 91.92CRMD : CORMEDIX INC 12.53XNCR : XENCOR INC -TBPH : THERAVANCE BIOPHARMA INC 9.12ZYME : ZYMEWORKS INC -KURA : KURA ONCOLOGY INC -ARCT : ARCTURUS THERAPEUTICS HOLDINGS INC -ZVRA : ZEVRA THERAPEUTICS INC 22.58

Definition of Enterprise Value over EBIT

[Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest and taxes [EBIT].
EV / EBIT
(=) EV/EBIT
EV/EBIT for ANAPTYSBIO INC is calculated as follows: EV [ $ 601.1M ] / EBIT [ $ -73.66M ]
(=) EV/EBIT [ 0 ]

ANAB - Enterprise Value over EBIT, Last 5 years

75.5

Minimum

Sep 30, 2021

75.5

Maximum

Sep 30, 2021

75.5

Average

75.5

Median

EV/EBIT Benchmark Analysis

The chart above depicts the distribution of EV/EBIT for companies in the Total Stock Market. The average EV/EBIT of the companies is 19.91 with a standard deviation of 12.32.
The following table provides additional summary stats:
EV/EBIT in the Market:
filtered constituents2.25K
min0.05
max62.03
average19.91
median16.78
std12.32